JPRN-UMIN000053045招募中Unknown
Prospective study of biomarkers and pharmacological characteristics for patients with metastatic lung tumors - Prospective study of biomarkers and pharmacological characteristics for patients with metastatic lung tumors
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 550
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are deemed by the principal investigator or subinvestigator to be inappropriate to conduct this study.
研究者
相似试验
已完成
不适用
Prospective research of the biomarkers associated with adjuvant chemotherapy in patients with resectable biliary tract cancerBiliary tract cancerJPRN-UMIN000004613Department of Medical Oncology, University of Miyazaki Hospital50
已完成
不适用
Research for biomarkers to predict the effectiveness of zoledronic acid in metastatic bone tumorsPatients with bone metastases newly treated by zoledronic acidJPRN-UMIN000018556agoya University Graduate School and School of Medicine27
已完成
不适用
Research for biomarkers to predict the effectiveness of denosumab in metastatic bone tumorsPatients with bone metastases newly treated by denosumabJPRN-UMIN000019700agoya University Graduate School and School of Medicine40
招募中
不适用
Exploratory study of biomarkers for therapeutic efficacy and immune-related adverse events of immune checkpoint inhibitorsAll cancer types indicated for immune checkpoint inhibitorJPRN-UMIN000043798Kumamoto University400
招募中
不适用
An exploratory prospective study of the biomarkers of the immune-related adverse events (irAE) and the mechanisms of irAE in solid cancer patients treated with Pembrolizumab.solid cancerJPRN-UMIN000028474Department of Internal Medicine, Division of Medical Oncology, Showa University School of Medicine.30